Empirical evaluation of artificial intelligence distillation techniques for ascertaining cancer outcomes from
Irbaz Bin Riaz1,2, Syed Arsalan Ahmed Naqvi3, Noman Ashraf4
1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. riaz.irbaz@mayo.edu.
Abstract:
Phenotypic information for cancer research is embedded in unstructured electronic health records (EHR), requiring effort to extract. Deep learning models can automate this but face scalability issues due to privacy concerns. We evaluated techniques for applying a teacher-student framework to extract longitudinal clinical outcomes from EHRs. We focused on the challenging task of ascertaining two cancer outcomes-overall response and progression according to Response Evaluation Criteria in Solid Tumors (RECIST)-from free-text radiology reports. Teacher models with hierarchical Transformer architecture were trained on data from Dana-Farber Cancer Institute (DFCI). These models labeled public datasets (MIMIC-IV, Wiki-text) and GPT-4-generated synthetic data. "Student" models were then trained to mimic the teachers' predictions. DFCI "teacher" models achieved high performance, and student models trained on MIMIC-IV data showed comparable results, demonstrating effective knowledge transfer. However, student models trained on Wiki-text and synthetic data performed worse, emphasizing the need for in-domain public datasets for model distillation.
More Related Videos
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Related Concept Videos
Cancer Survival Analysis
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Kaplan-Meier Approach
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
